Value of peri-operative chemotherapy in patients with CINSARC high-risk localized grade 1 or 2 soft tissue sarcoma: study protocol of the target selection phase III CHIC-STS trial.

导出 OA

翻译打印收藏纠错

作者： Thomas,Filleron ^[1] ; Sophie,Le Guellec ^[2] ; Christine,Chevreau ^[3] ; Bastien,Cabarrou ^[4] ; Tom,Lesluyes ^[5] ; Sabrina,Lodin ^[3] ; Angélique,Massoubre ^[6] ; Muriel,Mounier ^[6] ; Muriel,Poublanc ^[6] ; Frédéric,Chibon ^[6] ; Thibaud,Valentin ^[2]

作者单位： Biostatistics Unit, Institut Claudius Regaud, IUCT-O, 1 Avenue Irène Joliot Curie, 31059, Toulouse Cedex, France. Filleron.thomas@iuct-oncopole.fr. ^[1] Department of Pathology, Institut Claudius Regaud, IUCT-O, 1 Avenue Irène Joliot Curie, 31059, Toulouse, France. ^[2] INSERM U1037, Cancer Research Center of Toulouse (CRCT), Toulouse, France. ^[3] Department of Medical Oncology, Institut Claudius Regaud IUCT-O, 1 Avenue Irène Joliot Curie, 31059, Toulouse, France. ^[4] Biostatistics Unit, Institut Claudius Regaud, IUCT-O, 1 Avenue Irène Joliot Curie, 31059, Toulouse Cedex, France. ^[5] Clinical Trials Office, Institut Claudius Regaud, IUCT-O, 1 Avenue Irène Joliot Curie, 31059, Toulouse, France. ^[6]

关键词 CINSARC signature Chemotherapy Soft tissue sarcoma Target selection design